$XBI $136.53 -1.42%
COVID Updates
$OCGN -6.90% Ocugen’s COVID-19 Vaccine Co-Development Partner, Bharat Biotech, Shares Phase 3 Results Demonstrating 77.8% Protection against Overall Disease source
Pipeline Updates
$BCRX +1.29% ORLADEYO™ (berotralstat) Data to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress source
$CYDY 0% CytoDyn Submits Dose Justification Report to FDA to Begin Overcoming Deficiencies in its BLA for HIV source
$ITRM -37.99% Iterum Therapeutics Provides Regulatory Update source
$OBSV -1.34% ObsEva to Present Ebopiprant (OBE022) Data at the Society for Reproductive Investigation 68th Annual Meeting source $ARWR -25.69% Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study source
$ALEC +52.12% Alector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases source
$SURE +1.43% uniQure Announces Presentations at Upcoming International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress source $ANVS +9.16% Annovis Bio to Present Data at Alzheimer's Association International Conference 2021 Highlighting Positive Clinical Outcomes from Its Two Phase 2a Trials source
Financial Updates
$ZNTL -3.44% Zentalis Pharmaceuticals Announces Closing of Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares source
$BSGM -4.14% BioSig Announces Proposed Public Offering of Common Stock source
$CERE -13.86% Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock source $TLSA -4.26% Tiziana Life Science - Distribution Dates: shares and ADRs in Accustem source
$NTLA -4.63% Intellia Therapeutics Announces Closing of $690 Million Public Offering of Common Stock source
Posted by MV